Even in the era of the FDA’s Commissioner’s National Priority Voucher program, Jazz Pharmaceuticals is showing that traditional priority review vouchers can catch a pretty penny. More: JPM26: Jazz's 0M voucher sale shows drumbeat of rising prices isn't stopping Source:
read moreTo promote its newly launched nonhormonal menopause drug, Bayer is linking Lynkuet with a familiar face. More: Bayer taps Gabrielle Union-Wade as face of menopause med Lynkuet Source: fierce
read more
Acquisition expands PMGroup’s commitment to transforming workplace health and organisational resilience More: PMGroup Worldwide Ltd welcomes MAD World Summit Source: News
read more
Regulator accepts supplemental application supported by positive phase 3 data More: Argenx receives review from FDA for VYVGART in seronegative gMG Source: News
read moreAs part of its mission to make a dent in the sizable presbyopia market, Lenz Therapeutics has scoped out a star-studded partnership for its Vizz prescription eye drops. More: Lenz ups Vizz visibility with DTC campaign starring Sarah Jessica Parker
read moreAmneal Pharmaceuticals and VantAI have joined the ranks of companies to decide that a new year demands a new look, each unveiling fresh branding aligned with their respective plans for 2026. More: Amneal and VantAI unveil fresh branding to kick
read more© 1994 - 2026 B.M. Pharmaceuticals